Bovine parvovirus is a viral disease that affects cattle, caused by the bovine parvovirus (BPV), which belongs to the Parvoviridae family. Although it is often associated with subclinical infections, the disease is of significant public health importance, particularly due to its link to reproductive, enteric, and respiratory disorders, which impact herd productivity.
Bovine parvovirus is a small, non-enveloped virus that is highly resistant to environmental conditions and can remain viable for long periods in the environment. Transmission occurs primarily via the fecal-oral route, through contaminated feces, respiratory secretions, and fomites such as equipment, facilities, and utensils used in animal husbandry.
Clinically, infection with bovine parvovirus can present in various ways, depending on the animals’ age, viral load, and the presence of concurrent infections. In calves, it may be associated with diarrhea, growth retardation, and respiratory infections. In pregnant females, the infection has been linked to reproductive failures, including embryonic resorption, abortions, and the birth of weak calves.
Most infections with bovine parvovirus are subclinical, which facilitates the silent circulation of the virus within herds. However, its role as an immunosuppressive agent and as a facilitator of secondary infections underscores its importance in the context of animal health.
Prevention of bovine parvovirus relies primarily on management and biosecurity measures, including proper sanitation of facilities, control of animals entering the herd, quarantine, and proper health management of calves and pregnant females. There are no widely used commercial vaccines specifically targeting bovine parvovirus.
Laboratory diagnosis is essential for identifying the infection and for epidemiological studies. Molecular methods, such as PCR, enable the detection of the viral genome, while serological tests help assess the animals’ exposure to the virus.
Continuous epidemiological surveillance, combined with laboratory diagnosis and good management practices, is essential for monitoring the circulation of Bovine Parvovirus. These measures help reduce the impact on production, improve animal health, and ensure the sustainability of the cattle industry.
*]:pointer-events-auto scroll-mt-[calc(var(–header-height)+min(200px,max(70px,20svh)))]” dir=”auto” tabindex=”-1″ data-turn-id=”request-WEB:fe9b6517-792e-400f-9654-1c43d01eef55-34″ data-testid=”conversation-turn-70″ data-scroll-anchor=”true” data-turn=”assistant”>
In this context, Bioperfectus’ rapid test for Bovine Parvovirus (BPV) serves as a practical screening tool to support disease surveillance in cattle herds. The use of the rapid test allows for the rapid identification of suspect animals directly in the field, especially during investigations of reproductive, enteric, or respiratory conditions, aiding in the immediate adoption of management measures, strengthening biosecurity, and directing samples for confirmation via laboratory methods. Thus, the rapid test complements conventional diagnostic methods, contributing to the early detection of BPV circulation, the reduction of viral spread, and the strengthening of Bovine Parvovirus control strategies.
